Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-005054
Filing Date
2019-04-30
Accepted
2019-04-30 17:01:50
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cbmg_10q.htm 10-Q 1338174
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF cbmg_ex311.htm EX-31 21740
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE cbmg_ex321.htm EX-32 10204
4 IMAGE cbmg_10q018.jpg GRAPHIC 36965
  Complete submission text file 0001654954-19-005054.txt   3825321

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT cmbg-20190331.xml EX-101.INS 461952
6 XBRL TAXONOMY EXTENSION SCHEMA cmbg-20190331.xsd EX-101.SCH 38644
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmbg-20190331_cal.xml EX-101.CAL 53915
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmbg-20190331_def.xml EX-101.DEF 107478
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmbg-20190331_lab.xml EX-101.LAB 271433
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmbg-20190331_pre.xml EX-101.PRE 208802
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Filer) CIK: 0001378624 (see all company filings)

EIN.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36498 | Film No.: 19782872
SIC: 2836 Biological Products, (No Diagnostic Substances)